ANRO
Alto Neuroscience Inc
NYSE · Pharmaceuticals
$15.22
+1.11 (+7.87%)
Open$14.35
Previous Close$14.11
Day High$15.41
Day Low$13.91
52W High$20.91
52W Low$1.60
Volume—
Avg Volume226.1K
Market Cap472.83M
P/E Ratio—
EPS$-2.31
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+45.7% upside
Current
$15.22
$15.22
Target
$22.17
$22.17
$14.63
$22.17 avg
$27.87
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 112.34M | 107.15M | 117.41M |
| Net Income | 25.21M | 21.35M | 24.46M |
| Profit Margin | 22.4% | 19.9% | 20.8% |
| EBITDA | 29.11M | 29.85M | 33.13M |
| Free Cash Flow | 25.43M | 19.85M | 18.41M |
| Rev Growth | +16.8% | +14.3% | +23.4% |
| Debt/Equity | 0.26 | 0.26 | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |